BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27566563)

  • 21. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraductal papillary mucinous neoplasms of the pancreas: Clinical association with KRAS.
    Chang XY; Wu Y; Li Y; Wang J; Chen J
    Mol Med Rep; 2018 Jun; 17(6):8061-8068. PubMed ID: 29658583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas.
    Ikemoto T; Sugimoto K; Shimada M; Utsunomiya T; Morine Y; Imura S; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S
    J Gastroenterol Hepatol; 2015 Jan; 30(1):217-22. PubMed ID: 25041344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraductal papillary mucinous neoplasm: a clinicopathologic review.
    Augustin T; Vandermeer TJ
    Surg Clin North Am; 2010 Apr; 90(2):377-98. PubMed ID: 20362793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
    Fukuda A
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.
    Tulla KA; Maker AV
    Langenbecks Arch Surg; 2018 Mar; 403(2):151-194. PubMed ID: 29218397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm.
    Morimatsu K; Aishima S; Kayashima T; Hayashi A; Nakata K; Oda Y; Taguchi T; Tsuneyoshi M; Tanaka M; Oda Y
    Pathobiology; 2012; 79(2):107-14. PubMed ID: 22286087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
    Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
    Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms.
    Yu J; Sadakari Y; Shindo K; Suenaga M; Brant A; Almario JAN; Borges M; Barkley T; Fesharakizadeh S; Ford M; Hruban RH; Shin EJ; Lennon AM; Canto MI; Goggins M
    Gut; 2017 Sep; 66(9):1677-1687. PubMed ID: 27432539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.
    Sparr JA; Bandipalliam P; Redston MS; Syngal S
    Am J Surg Pathol; 2009 Feb; 33(2):309-12. PubMed ID: 18987546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm.
    Ogawa T; Horaguchi J; Fujita N; Noda Y; Kobayashi G; Ito K; Koshita S; Kanno Y; Masu K; Sugita R
    J Hepatobiliary Pancreat Sci; 2014 Nov; 21(11):801-8. PubMed ID: 25082473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Satoh K; Hamada S; Kanno A; Hirota M; Umino J; Ito H; Masamune A; Egawa S; Unno M; Shimosegawa T
    J Gastroenterol; 2010 Jul; 45(7):763-70. PubMed ID: 20107842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer.
    Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Maekawa S; Mochizuki K; Kawaida H; Kono H; Itakura J; Sato T; Ichikawa D; Enomoto N
    Pancreas; 2019 Sep; 48(8):1032-1040. PubMed ID: 31404021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
    Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G
    Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
    Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T
    Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing.
    Kuratomi N; Takano S; Fukasawa M; Maekawa S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Takada H; Nakakuki N; Kato R; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Inoue T; Kondo T; Ichikawa D; Enomoto N
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease.
    Sadot E; Basturk O; Klimstra DS; Gönen M; Lokshin A; Do RK; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Allen PJ
    Ann Surg; 2015 Dec; 262(6):1102-7. PubMed ID: 25563865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
    Tanaka M
    Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.
    Nissim S; Idos GE; Wu B
    Pancreas; 2012 Nov; 41(8):1195-205. PubMed ID: 22750975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.